Other cardiac drugs
Meldonium is a carnitine precursor, a structural analogue of gamma-butyrobetaine (GBB) in which one carbon atom is replaced by a nitrogen atom. Its effect on the body can be explained in two ways.
In complex therapy of the following diseases:
– cardiovascular diseases: stable angina, chronic heart failure (NYHA Functional Class I-III), cardiomyopathy, functional cardiovascular disorders;
– acute and chronic ischemic cerebrovascular disorders;
– reduced work performance, physical and psychoemotional stress;
– during recovery from cerebrovascular disorders, head injury, and encephalitis.
Administer intravenously. The use of the drug does not require special preparation before administration. Due to the potential excitatory effect, the drug is recommended for administration in the morning.
Cardiovascular diseases; cerebrovascular disorders
The dose is 500 mg–1000 mg (5–10 ml) per day, the dose should be administered at once or divided into 2 doses. The maximum daily dose is 1000 mg.
Reduced work performance, physical and psychoemotional stress and recovery period after cerebrovascular disorders, head injury, and encephalitis
The dose is 500 mg (5 ml) per day. The maximum daily dose is 500 mg.
The duration of treatment is 4–6 weeks. The treatment course can be repeated 2–3 times a year.
No data on meldonium safety and efficacy in children under 18 years of age is available, therefore the use of meldonium in this category of patients is contraindicated.